US2009081256A1PendingUtilityA1
Transgenic plant-based vaccines
Est. expiryOct 7, 2017(expired)· nominal 20-yr term from priority
A61K 2039/6037C07K 14/62C12N 15/8258A61K 48/00C07K 2319/55C07K 14/28C12N 9/88A61K 39/12C07K 2319/00C12N 15/8216A61P 29/00C12N 2720/12334A61K 39/00
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of inducing partial or complete immunity to an infectious disease in a mammal comprising providing to the mammal for oral consumption an effective amount of a protein complex comprising five monomeric fusion proteins.
Claims
exact text as granted — not AI-modified1 . A method of producing an immunogen in a plant comprising cultivating a transgenic plant transformed with a DNA construct that encodes, upon expression in a plant cell, a protein complex comprising a multimeric cholera toxin B subunit and a an immunogenic antigen from a causal factor of a first mammalian disease under conditions effective to express the protein complex.
2 . A method of producing an immunogen in a plant comprising cultivating a transgenic plant transformed with a DNA construct that encodes, upon expression in a plant cell, a protein complex comprising a cholera toxin A2 subunit, a multimeric cholera toxin B subunit, a first immunogenic antigen from a causal factor of a first mammalian disease, and a second immunogenic antigen from a causal factor of a second mammalian disease under conditions effective to express the protein complex.
3 . The method of claim 1 , where the multimeric cholera toxin B subunit comprises five monomeric fusion proteins.
4 . The method of claim 3 , where the immunogenic antigen is NSP4 antigen from rotavirus, and where each fusion protein further comprises a cholera toxin B subunit linked to an NSP4 antigen from rotavirus.
5 . The method of claim 3 , where the protein complex further comprises ETEC fimbrial antigen CFA/1 from enterotoxigenic E. coli.
6 . The method of claim 1 , where the DNA construct comprises a bidirectional promoter controlling transcription of the DNA construct.
7 . A plant produced according to the method of claim 1 .
8 . A plant produced according to the method of claim 3 .
9 . A plant produced according to the method of claim 4 .
10 . A plant produced according to the method of claim 5 .
11 . A plant produced according to the method of claim 6 .
12 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 7 .
13 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 8 .
14 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 9 .
15 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 10 .
16 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 11 .
17 . The method of claim 2 , where the multimeric cholera toxin B subunit comprises five monomeric fusion proteins.
18 . The method of claim 17 , where the first immunogenic antigen is NSP4 antigen from rotavirus, and where each fusion protein further comprises a cholera toxin B subunit linked to an NSP4 antigen from rotavirus.
19 . The method of claim 17 , where the second immuogenic antigen is ETEC fimbrial antigen CFA/1 from enterotoxigenic E. coli.
20 . The method of claim 2 , where the DNA construct comprises a bidirectional promoter controlling transcription of the DNA construct.
21 . A plant produced according to the method of claim 2 .
22 . A plant produced according to the method of claim 17 .
23 . A plant produced according to the method of claim 18 .
24 . A plant produced according to the method of claim 19 .
25 . A plant produced according to the method of claim 20 .
26 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 21 .
27 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 22 .
28 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 23 .
29 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 24 .
30 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 25 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.